The normal function of the small presynaptic protein α-synuclein (α-syn) is of exceptional interest, not only in the context of neurodegeneration, but also as a cytosolic regulator of neurotransmission ([@r1]). Over the years, two seemingly divergent views have emerged. In one, α-syn binds to VAMP2 (synaptobrevin-2) and chaperones SNARE complexes, but with no effect on neurotransmission ([@r2]). Alternatively, we and others have advocated the concept that α-syn is a physiologic attenuator of neurotransmitter release, based on evidence that modest α-syn overexpression attenuates synaptic vesicle (SV) recycling and exocytosis ([@r3][@r4][@r5][@r6]--[@r7]). Furthermore, we proposed a model where α-syn helps in physiologic clustering of SV pools, restricting their egress to the presynaptic plasma membrane, thus attenuating SV recycling ([@r6]). Here, we asked if the two seemingly divergent views can be reconciled.

Results and Discussion {#s1}
======================

Although previous studies have documented α-syn--VAMP2 binding, some have reportedly failed to detect such associations ([@r8]). Interaction at synapses is also unclear. In support of ref. [@r2], our coimmunoprecipitation (co-IP) experiments show that full-length α-syn \[amino acids 1 to 140 (α-syn 1--140)\] binds VAMP2, whereas a deletion lacking the reported VAMP2-binding region (α-syn 1--95, see ref. [@r2]) does not ([Fig. 1 *A* and *B*](#fig01){ref-type="fig"}). To validate α-syn--VAMP2 interaction at synapses, we used the bimolecular fluorescence complementation (BiFC) assay, where candidate interacting proteins are tagged to N- and C-terminal Venus fragments (VN and VC) that are reconstituted upon interaction of the protein partners ([@r6]). Indeed, there was robust complementation of VAMP2:VN and α-syn 1--140:VC (but not VAMP2:VN and α-syn 1--95:VC) in HEK cells and presynaptic boutons ([Fig. 1 *C*--*E*](#fig01){ref-type="fig"})---the latter indicating synaptic α-syn--VAMP2 interactions.

![α-Syn sequence lacking the VAMP2-binding domain fails to attenuate SV recycling. (*A* and *B*) α-Syn sequence (*A*) and co-IP of α-syn--VAMP2 (*B*). Neuro2a cells were cotransfected with myc-tagged α-syn and VAMP2 and then immunoprecipitated with an anti-myc antibody. Note that α-syn 96--140 is the VAMP2-binding region (repeated twice). (*C*) Principle of our BiFC assay. (*D*) HEK cells were transfected with VN:VAMP2 and α-syn:VC (α-syn 1--140 or 1--95). Note punctate fluorescence with VN:VAMP2 + α-syn(1--140):VC, which was greatly attenuated with α-syn 1--95 sequence lacking VAMP2-binding domain; quantification of data shown *Right* (mean ± SEM; α-syn 1--140, 1 ± 0.06499, *n* = 38 from 3 independent experiments; α-syn 1--95, 0.3074 ± 0.01676, *n* = 39; \*\*\*\**P* \< 0.0001). (*E*) Cultured hippocampal neurons were cotransfected with the constructs listed; note α-syn--VAMP2 Venus complementation at boutons with WT α-syn; quantification shown *Right* (mean ± SEM from 2 independent experiments; α-syn 1--140, 1 ± 0.03949, *n* = 280; α-syn 1--95, 0.1691 ± 0.007379, *n* = 312; \*\*\*\**P* \< 0.0001). (*F*) α-Syn 1--110 contains the VAMP2-binding site that starts at amino acid 96. (*G*) Principle of pHluorin assay (*Top*) with representative images (*Below*). (*H* and *I*) Experiments in cultured hippocampal neurons (pHluorin). (*H*) While α-syn 1--110 attenuates SV recycling (*Left*), α-syn 1--95 has no effect (*Right*) (note that some error bars are too small to see). (*I*) Quantification of data in *H* (mean ± SEM from at least 3 independent experiments); control, 0.4703 ± 0.03215, *n* = 16; α-syn 1--140, 0.3165 ± 0.02914, *n* = 13; α-syn 1--110, 0.3464 ± 0.05906, *n* = 8; α-syn 1--95, 0.4763 ± 0.0192, *n* = 17; \*\**P* = 0.0025, \**P* = 0.0459 (one-way ANOVA followed by Dunnett's post hoc test).](pnas.1903049116fig01){#fig01}

A previous study showed that overexpression of an α-syn sequence lacking the C terminus (α-syn 1--110) also attenuated SV recycling ([@r4]), leading to the notion that VAMP2 binding may not be critical for synaptic function. However, we noticed that the α-syn 1--110 sequence used in ref. [@r4] has a 15-aa region (α-syn 96--110) that overlaps with the reported VAMP2-binding site that starts at amino acid 96 (see [Fig. 1*F*](#fig01){ref-type="fig"}). Accordingly, we first asked if α-syn 1--95---a sequence that definitively lacks the VAMP2-binding site---can attenuate SV recycling in pHluorin assays ([@r6]) that report exo/endocytic cycles as fluctuations of SV luminal fluorescence (see [Fig. 1*G*](#fig01){ref-type="fig"}). Interestingly, while α-syn 1--110 attenuated SV recycling, α-syn 1--95 had no effect ([Fig. 1 *H* and *I*](#fig01){ref-type="fig"}).

In co-IP experiments, α-syn 1--140 and 1--110 bound VAMP2 with equal affinity ([Fig. 2*A*](#fig02){ref-type="fig"}), suggesting that α-syn 96--110 might be the VAMP2-binding domain. Indeed, scrambling the α-syn 96--110 amino acids abrogated α-syn--VAMP2 interaction ([Fig. 2*B*](#fig02){ref-type="fig"}). To narrow down the amino acid region required for binding, we did alanine scanning of the α-syn 96--110 region, sequentially mutating amino acids starting at α-syn 96 to alanine---an inert methyl functional group mimicking secondary structures of other amino acids ([Fig. 2*C*](#fig02){ref-type="fig"}). As shown in [Fig. 2*D*](#fig02){ref-type="fig"}, the first ∼9 amino acids starting at α-syn 96 seem critical for VAMP2 binding in this setting. However, we note that other C-terminal sequences may also be important, particularly if such interactions do not affect SV recycling. Finally, these α-syn--VAMP2 deletions and subtle mutations also abrogated α-syn effects on SV recycling ([Fig. 2 *E* and *F*](#fig02){ref-type="fig"}).

![Mapping of the α-syn--VAMP2 binding domain and requirement of α-syn--VAMP2 interactions for α-syn--mediated SV attenuation. (*A* and *B*) Both α-syn 1--140 and 1--110 bind VAMP2 with equal affinity, and scrambling of amino acid sequences in α-syn 96--110 attenuates α-syn--VAMP2 binding (co-IP in neuro2a, repeated twice). (*C* and *D*) Sequential amino acids (from α-syn 96) were mutated to alanine, and association of these mutants (myc-tagged) with VAMP2 was evaluated (co-IP in neuro2a cells). Note that mutations in α-syn 96--104 show the greatest disruption (repeated twice). (*E*) Scrambled and KKD mutations in the α-syn 96--110 sequence abrogated α-syn--mediated synaptic attenuation, as determined by pHluorin assays in hippocampal neurons. (*F*) Quantification of data in *E* (mean ± SEM from at least 3 independent experiments); control, 0.423 ± 0.029, *n* = 6; α-syn 1--140, 0.178 ± 0.032, *n* = 6; KKD, 0.453 ± 0.070, *n* = 5; Scr-1, 0.464 ± 0.041, *n* = 6; \*\**P* = 0.0017 (one-way ANOVA followed by Dunnett's post hoc test). (*G*--*I*) Optical single vesicle clustering experiments were carried out as described in ref. [@r10]. Briefly, VAMP2-containing synaptic-like vesicles were first immobilized on a glass slide assembled in a microfluidic chamber, and then WT or mutant α-syn protein was added. After extensive washing (to remove unbound α-syn), DiI-labeled VAMP2-containing vesicles were added to the chamber, and clustering of the labeled vesicles was visualized by prism-type total internal reflection fluorescence microscopy (after extensive washing to remove unbound vesicles). As shown in representative images (*G*) and quantitative data (*H*), α-syn induced vesicle clustering, and deletions or subtle mutations in the VAMP2-binding site markedly abrogated the number of vesicle clusters. Mean ± SEM from 4 independent experiments where observer was blinded to the conditions; α-syn 1--140, 100%; α-syn 1--110, 83.15% ± 6.439%; no α-syn, 21.83% ± 7.437%; α-syn 1--95, 29.94% ± 8.332%; KKD, 33.89% ± 3.465%; Scr-1, 30.49% ± 8.138%; NS, nonsignificant; \*\*\*\**P* \< 0.001 (one-way ANOVA followed by Dunnett's post hoc test). (*I*) Scatter plots showing number of vesicle clusters (on *y* axis) and fluorescence intensities (on *x* axis) of all Dil-labeled clusters, along with a smoothened curve through the data points.](pnas.1903049116fig02){#fig02}

Previously, we found that α-syn multimers appear to cluster SVs ([@r6]), resembling phenotypes in yeast where α-syn induced vesicle clusters ([@r9]). Here, we used a single-vesicle optical microscopy system to directly visualize α-syn--induced clustering of small synaptic-like vesicles in vitro ([Fig. 2*G*](#fig02){ref-type="fig"}; see ref. [@r10] for details of methods). As shown in [Fig. 2 *H* and *I*](#fig02){ref-type="fig"}, α-syn 1--140 induced vesicle clustering, whereas any perturbation in the α-syn--VAMP2 binding region abrogated this effect. Synaptic targeting of α-syn deletions/mutations---determined by a quantitative ratiometric paradigm ([@r11])---was comparable to wild-type (WT) α-syn (targeting of α-syn 1--110, α-syn 1--95, KKD, and Scr-1 was ∼93%, 86%, 98%, and 95% of the WT protein, respectively; changes were statistically nonsignificant).

Taken together, the data indicate that α-syn--VAMP2 binding is essential for α-syn function and advocate an "interlocking model" where α-syn multimers on the SV surface interact with VAMP2 on adjacent SVs, helping to maintain physiologic SV clustering. An understanding of normal α-syn function is likely critical to appreciate pathologic triggers in disease ([@r12], [@r13]). Degradation of α-syn by chaperone-mediated autophagy (CMA) is strongly implicated in synucleinopathies, and interestingly, a pentapeptide region consistent with a CMA recognition motif---α-syn 95--99 (see ref. [@r14])---also lies within the VAMP2-binding site. Thus, this small region in the C terminus of α-syn may be a key "hub" in pathophysiologic transition. Our findings link divergent views in the field and offer a unified model of α-syn function that provides a new platform for future studies probing the pathobiology of this enigmatic protein. Along with the paper in PNAS by Atias et al. ([@r15]), the collective evidence points to a scenario where VAMP2 and synapsin (another cytosolic presynaptic protein with known roles in SV clustering) cooperate to help cluster SVs and regulate SV recycling. Whereas VAMP2 and α-syn directly induce SV clustering, synapsin assists in clustering by enhancing α-syn targeting to SVs, perhaps by facilitating the axonal transport of α-syn (see ref. [@r15] for details).
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